Statera Biopharma closes $5.7M public offering
FORT COLLINS — Statera Biopharma (Nasdaq: STAB) has closed a $5.7 million public offering, the company announced Friday. Statera offered […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
A new Foothills — again
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…
Statera Biopharma reports $101M loss for 2021 fiscal year
FORT COLLINS — Drug manufacturing company Statera Biopharma Inc. (Nasdaq: STAB) posted a $101.8 million loss for the 2021 fiscal…
NoCo startup scores investment on Shark Tank
LOVELAND — Another Colorado startup, this one from Loveland, has joined the pantheon of regional companies in the exclusive club…
Statera Biopharma set for Nasdaq delisting hearing
FORT COLLINS — Statera Biopharma (Nasdaq: STAB) will have a hearing Oct. 6 before the Nasdaq Hearings Panel to determine…